44 related articles for article (PubMed ID: 27890422)
1. Treatment efficacy of CT-guided percutaneous microwave ablation for primary hepatocellular carcinoma.
Yin T; Li W; Zhao P; Wang Y; Zheng J
Clin Radiol; 2017 Feb; 72(2):136-140. PubMed ID: 27890422
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of microwave ablation with parallel acupuncture guided by ultrasound in treating single hepatocellular carcinoma in high-risk areas: A retrospective analysis of 155 patients.
Liu S; Zhou P; Shen Q; Qian G
J Cancer Res Ther; 2024 Apr; 20(2):547-554. PubMed ID: 38687924
[TBL] [Abstract][Full Text] [Related]
3. [Curative effect of percutaneous microwave ablation therapy on hepatocellular carcinoma survival: a 15-year real-world study].
Luo YC; Lang ML; Cai WJ; Han ZY; Liu FY; Cheng ZG; Yu XL; Dou JP; Li X; Tan SL; Dong XJ; Liang P; Yu J
Zhonghua Gan Zang Bing Za Zhi; 2024 Apr; 32(4):332-339. PubMed ID: 38733188
[No Abstract] [Full Text] [Related]
4. Computed tomography-guided percutaneous cryoablation and microwave ablation in the treatment of perivascular hepatocellular carcinoma: A comparative study with propensity score matching.
Li B; Ren ZW; Zhang C; Yu XX; Xu XX; Du Y; Yang HF
Clin Res Hepatol Gastroenterol; 2024 Mar; 48(3):102298. PubMed ID: 38367802
[TBL] [Abstract][Full Text] [Related]
5. [Predictive value of aMAP risk score for early recurrence of small hepatocellular carcinoma after microwave ablation].
Dong SY; Deng SY; Fan R; Chen JZ; Cheng X; Hao X; Dai WC
Zhonghua Nei Ke Za Zhi; 2023 Nov; 62(11):1329-1334. PubMed ID: 37935500
[No Abstract] [Full Text] [Related]
6. Percutaneous stereotactic image-guided microwave ablation for malignant liver lesions.
Perrodin S; Lachenmayer A; Maurer M; Kim-Fuchs C; Candinas D; Banz V
Sci Rep; 2019 Sep; 9(1):13836. PubMed ID: 31554853
[TBL] [Abstract][Full Text] [Related]
7. A Recent Advance in Image-Guided Locoregional Therapy for Hepatocellular Carcinoma.
Shi Y; Zhai B
Gastrointest Tumors; 2016 Oct; 3(2):90-102. PubMed ID: 27904861
[TBL] [Abstract][Full Text] [Related]
8. Patterns of sorafenib and TACE treatment of unresectable hepatocellular carcinoma in a Chinese population: subgroup analysis of the GIDEON study.
Liu F; Meng Z; Shao G; Wang J; Wang Z; Yang J; Yip CS; He D
Mol Biol Rep; 2017 Feb; 44(1):149-158. PubMed ID: 27981445
[TBL] [Abstract][Full Text] [Related]
9. Radiation Segmentectomy versus TACE Combined with Microwave Ablation for Unresectable Solitary Hepatocellular Carcinoma Up to 3 cm: A Propensity Score Matching Study.
Biederman DM; Titano JJ; Bishay VL; Durrani RJ; Dayan E; Tabori N; Patel RS; Nowakowski FS; Fischman AM; Kim E
Radiology; 2017 Jun; 283(3):895-905. PubMed ID: 27930089
[TBL] [Abstract][Full Text] [Related]
10. The Role of Dual-Phase Cone-Beam CT in Predicting Short-Term Response after Transarterial Chemoembolization for Hepatocellular Carcinoma.
Müller K; Datta S; Gehrisch S; Ahmad M; Mohammed MA; Rosenberg J; Hwang GL; Louie JD; Sze DY; Kothary N
J Vasc Interv Radiol; 2017 Feb; 28(2):238-245. PubMed ID: 27914917
[TBL] [Abstract][Full Text] [Related]
11. Volasertib suppresses the growth of human hepatocellular carcinoma
Zheng DW; Xue YQ; Li Y; Di JM; Qiu JG; Zhang WJ; Jiang QW; Yang Y; Chen Y; Wei MN; Huang JR; Wang K; Wei X; Shi Z
Am J Cancer Res; 2016; 6(11):2476-2488. PubMed ID: 27904765
[TBL] [Abstract][Full Text] [Related]
12. Complete response with sorafenib and transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma.
Takano M; Kokudo T; Miyazaki Y; Kageyama Y; Takahashi A; Amikura K; Sakamoto H
World J Gastroenterol; 2016 Nov; 22(42):9445-9450. PubMed ID: 27895433
[TBL] [Abstract][Full Text] [Related]
13. Combination of transcatheter arterial chemoembolization and CT-guided percutaneous segment ablation for hepatocellular carcinoma therapy: A retrospective study.
Li W; Wang Y; Gao W; Zheng J
Medicine (Baltimore); 2016 Nov; 95(47):e5422. PubMed ID: 27893681
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency Ablation and Microwave Ablation in Liver Tumors: An Update.
Izzo F; Granata V; Grassi R; Fusco R; Palaia R; Delrio P; Carrafiello G; Azoulay D; Petrillo A; Curley SA
Oncologist; 2019 Oct; 24(10):e990-e1005. PubMed ID: 31217342
[TBL] [Abstract][Full Text] [Related]
15. Acetic acid versus radiofrequency ablation for the treatment of hepatocellular carcinoma: A randomized controlled trial.
Paul SB; Acharya SK; Gamanagatti SR; Sreenivas V; Shalimar S; Gulati MS
Diagn Interv Imaging; 2020 Feb; 101(2):101-110. PubMed ID: 31302075
[TBL] [Abstract][Full Text] [Related]
16. A double blinded prospective randomized trial comparing the effect of anatomic versus non-anatomic resection on hepatocellular carcinoma recurrence.
Feng X; Su Y; Zheng S; Xia F; Ma K; Yan J; Li X; Tang W; Wang S; Bie P; Dong J
HPB (Oxford); 2017 Aug; 19(8):667-674. PubMed ID: 28499749
[TBL] [Abstract][Full Text] [Related]
17. Comparable and Complimentary Modalities for Treatment of Small-Sized HCC: Surgical Resection, Radiofrequency Ablation, and Microwave Ablation.
Wicks JS; Dale BS; Ruffolo L; Pack LJ; Dunne R; Laryea MA; Hernandez-Alejandro R; Sharma AK
J Clin Med; 2023 Jul; 12(15):. PubMed ID: 37568408
[TBL] [Abstract][Full Text] [Related]
18. Clinical Results, Risk Factors, and Future Directions of Ultrasound-Guided Percutaneous Microwave Ablation for Hepatocellular Carcinoma.
Dong TT; Wang L; Li M; Yin C; Li YY; Nie F
J Hepatocell Carcinoma; 2023; 10():733-743. PubMed ID: 37215363
[TBL] [Abstract][Full Text] [Related]
19. Comparative Study of Application of Computed Tomography/Ultrasound and Computed Tomography Imaging Guidance Methods in the Microwave Ablation of Liver Cancer.
Liang J; Zhang S; Han Z; Li Y; Sun H; Kim Y; Kim T
J Comput Assist Tomogr; 2023 Jan-Feb 01; 47(1):24-30. PubMed ID: 36055224
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
